Tri-lo-marzia Kit
Product Images NDC 63187-754

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tri-lo-marzia (NDC 63187-754). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wallet (38102227 8293 4c7f 9a89 F0050d8046c5 01)

This image shows a dosage calendar for TRI-LO-MARZIA (norgestimate and ethinyl estradiol tablets USP) outlining a 4-week cycle arranged by weekdays from Sunday to Saturday. Dosages for three active tablets are listed: 0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg. Instructions include labeling for correct start day, and storage conditions advising 25°C (77°F) with allowed variations, protecting from light. The label also refers to a monthly self breast exam reminder.*

FDA Label Image

Image Structure (38102227 8293 4c7f 9a89 F0050d8046c5 02)

Chemical structure diagram showing the molecular structures of the active ingredients norgestimate and ethinyl estradiol, labeled below each respective structure.*

FDA Label Image

63187-754-28 (38102227 8293 4c7f 9a89 F0050d8046c5 05)

Label for TRI-LO-MARZIA kit containing norgestimate and ethinyl estradiol USP, 28 day tablets in a 1x28 count package. Labeled by Proficient Rx LP, Thousand Oaks, CA, with manufacturer Lupin Limited, India. The label includes NDC 63187-754-28, storage instructions at 25°C, and multiple small patient labels with lot, expiration, and serial number placeholders.*

FDA Label Image

Image A-w Wallet (Image 01)

The image shows a dosing calendar for the prescription drug kit TRI-LO-MARZIA containing norgestimate and ethinyl estradiol in varying strengths (0.180 mg/0.025 mg, 0.215 mg/0.025 mg, and 0.250 mg/0.025 mg). It includes weekly rows labeled Week 1 through Week 4, with days Sunday to Saturday marked for tracking daily pill intake. Instructions indicate starting on Sunday and following arrows for daily use. Storage conditions are noted at the bottom (store at 25°C with allowable excursions). The label also references performing a monthly self breast exam.*

FDA Label Image

Image Med Guide (Image 02)

A vertical bar chart illustrating pregnancy rates per 100 women over one year with different birth control methods. The y-axis ranges from "85 or more pregnancies" (bottom) to "Fewer than 1 pregnancy" (top). Methods like implants, injections, intrauterine devices, and sterilization show the fewest pregnancies; birth control pills, skin patches, and vaginal rings with hormones have slightly higher pregnancy rates; condoms and diaphragms show more; and no birth control results in the most pregnancies.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.